About Bilcare Limited
Data last updated:
Bilcare Limited is a public limited company based in Pune, Maharashtra, India. It operates in the packaging films and foils segment of the packaging sector. It was incorporated on 01 July 1987 and has been in existence for over 39 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN L28939PN1987PLC043953. Its GSTIN is 27AABCB2242F1Z6 (Maharashtra). The company holds 4 GST registrations, of which 1 is active. Its shares are listed on BSE: 526853 and NSE: BI.
The company has an authorised share capital of ₹45 Cr and a paid-up capital of ₹23.55 Cr. It was formerly known as Bhandari Paper Products Private Limited. It is led by directors including Shreyans Mohan Bhandari (Managing Director) and Kavita Bhansali (Whole-Time Director).
Its last annual general meeting (AGM) was held on 24 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Gat No 1028 At Village Shiroli Tal Khed Rajgurnagar, Pune, Maharashtra, India – 410505.
As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹733.54 Cr, a decline of 6.9% compared to the previous year. For the same year it recorded a net profit of ₹5.52 Cr (net margin 0.8%) and EBITDA of ₹40.63 Cr (EBITDA margin 5.5%). The net worth stands at ₹196.73 Cr (down 8.2% YoY). Total assets are valued at ₹707.69 Cr (down 11.1% YoY).
The company has about 70 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 1 brand: Bilcare. As per MCA filings, the company has open charges of ₹666.96 Cr and satisfied charges of ₹3,764.67 Cr on record. Court records list 136 cases involving the company, including 52 filed by the company and 75 filed against it; 33 cases are pending. The company has 37 deals on record (30 market trades, 7 funding rounds), with disclosed funding of ₹475.94 Cr; the latest was in September 2026. Its 10 peer companies in the Packaging industry (Films and Foils, Pharma Packaging) are compared by revenue, 5 larger and 5 smaller; the largest is Acg Pharmapack Private Limited with revenue of ₹1,273.79 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website bilcare.com.
CIN History of Bilcare Limited
Bilcare has one previous CIN (Corporate Identification Number): U28939PN1987PLC043953. The current CIN is L28939PN1987PLC043953, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L28939PN1987PLC043953 | Current |
| U28939PN1987PLC043953 | Previous |
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressGat No 1028 At Village Shiroli Tal Khed Rajgurnagar, Pune, Maharashtra, India – 410505
- IndustryPackaging, Packaging Films & Foils, Pharmaceutical Packaging Solutions
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands with Bilcare Limited
Bilcare operates one associated brand: Bilcare. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical packaging, clinical supplies, and anti-counterfeiting solutions are provided. | bilcare.com |
Business Activity of Bilcare Limited
The main business activity of Bilcare is support service to organizations. In detail, this covers other support services to organizations.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| N | Support service to Organizations | N7 | Other support services to organizations | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Bilcare Limited FY 2025-26 filings available
Bilcare Limited reported revenue of ₹733.54 Cr (down 6.9% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · ConsolidatedRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 734 | 788 | 747 | 982 | 845 | 623 | 1,827 |
| Revenue growth | -6.9% | +5.5% | -23.9% | +16.2% | +35.7% | -65.9% | - |
| EBITDA | 40.63 | 24.79 | 32.51 | (26.13) | 56.86 | 46.36 | 43.99 |
| EBITDA margin | +5.5% | +3.2% | +4.4% | -2.7% | +6.7% | +7.4% | +2.4% |
| Profit before tax | (21.46) | (71.34) | (71.71) | 196 | (4.22) | (24.96) | (114) |
| Net profit | 5.52 | (25.26) | (32.14) | (66.54) | (42.65) | (42.56) | (299) |
| Net profit margin | +0.8% | -3.2% | -4.3% | -6.8% | -5.1% | -6.8% | -16.4% |
| EPS (₹) | 0.73 | (12.23) | (14.12) | 6.39 | (5.35) | (8.95) | (43.97) |
| Balance sheet | |||||||
| Total assets | 708 | 796 | 1,406 | 1,346 | 877 | 898 | 948 |
| Net worth | 197 | 214 | 498 | 531 | 75.15 | 86.31 | 108 |
| Total debt | 620 | 689 | 756 | 639 | 690 | 677 | 707 |
| Cash & bank | 5.51 | 15.01 | 36.42 | 30.83 | 40.07 | 56.64 | 64.13 |
| Net working capital | 222 | 222 | 272 | 128 | 171 | 171 | 202 |
| Cash flow | |||||||
| Cash from operations | 128 | 86.41 | 62.46 | (6.98) | 41.27 | 71.79 | 256 |
| Cash from investing | (5.02) | 81.41 | (106) | 36.20 | (4.26) | 1.65 | 1,309 |
| Cash from financing | (132) | (171) | 35.89 | (18.90) | (54.88) | (82.68) | (1,600) |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 226 | 188 | 181 | 178 | 186 | 194 | 198 | 202 |
| Revenue growth (YoY) | +21.2% | -3.3% | -8.5% | -11.7% | -4.0% | - | - | - |
| Other income | 1.75 | 14.46 | 5.14 | 4.32 | 6.08 | 21.16 | 3.44 | 3.91 |
| EBITDA | 35.28 | 14.93 | 11.21 | 3.42 | 11.07 | 7.68 | 0.75 | (2.28) |
| EBITDA margin | +15.6% | +8.0% | +6.2% | +1.9% | +5.9% | +4.0% | +0.4% | -1.1% |
| Depreciation | 4.11 | 4.78 | 5.01 | 12.23 | 11.56 | 4.66 | 11.74 | 11.04 |
| Interest | 18.08 | 17.69 | 17.04 | 19.06 | 18.55 | 18.68 | 19.48 | 23.68 |
| Profit before tax | 14.84 | 6.92 | (5.70) | (23.55) | (12.96) | 5.50 | (27.03) | (33.09) |
| Tax | (0.13) | (0.93) | 0.19 | (0.23) | (3.20) | (6.56) | (10.79) | (3.16) |
| Net profit | 14.97 | 7.85 | (5.89) | (23.32) | (9.76) | 12.06 | (16.24) | (29.93) |
| EPS (₹) | 5.39 | 5.68 | 0.41 | (5.25) | (1.61) | 7.47 | (3.05) | (6.81) |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 6.85 | 15.12 | 17.60 | 13.98 | 430 | 304 | 212 |
| Revenue growth | -54.7% | -14.1% | +25.9% | -96.8% | +41.3% | +43.6% | - |
| EBITDA | (14.65) | (5.67) | (13.31) | (87.82) | 31.28 | 20.55 | (247) |
| EBITDA margin | -213.9% | -37.5% | -75.6% | -628.2% | +7.3% | +6.8% | -116.7% |
| Profit before tax | 1.56 | 5.46 | 5.69 | 503 | (23.53) | (17.63) | (127) |
| Net profit | 2.58 | 2.14 | (10.80) | (8.82) | (51.33) | (52.79) | (126) |
| Net profit margin | +37.7% | +14.2% | -61.4% | -63.1% | -11.9% | -17.4% | -59.7% |
| EPS (₹) | 0.42 | 1.70 | 2.27 | 165.97 | (7.55) | 0.76 | (43.46) |
| Balance sheet | |||||||
| Total assets | 433 | 434 | 426 | 418 | 757 | 793 | 831 |
| Net worth | 421 | 420 | 416 | 410 | 43.41 | 60.72 | 59.18 |
| Total debt | 11.87 | 11.04 | 10.29 | 7.52 | 690 | 678 | 709 |
| Cash & bank | 1.30 | 3.49 | 2.05 | 11.98 | 4.52 | 7.81 | 5.44 |
| Net working capital | 49.45 | 67.11 | 56.96 | (12.56) | (0.70) | 7.66 | (51.61) |
| Cash flow | |||||||
| Cash from operations | 11.57 | 2.36 | 97.63 | 397 | 46.29 | (0.41) | 71.12 |
| Cash from investing | (14.05) | 2.94 | (107) | 181 | 5.59 | 85.02 | 10.82 |
| Cash from financing | 0.24 | (3.85) | (0.51) | (571) | (55.47) | (82.28) | (83.03) |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.94 | 1.20 | 1.73 | 1.85 | 2.07 | 4.13 | 3.36 | 2.76 |
| Revenue growth (YoY) | -6.3% | -70.9% | -48.5% | -33.0% | -57.5% | - | - | - |
| Other income | 4.36 | 3.82 | 5.54 | 3.45 | 6.72 | 6.45 | 3.78 | 3.78 |
| Total expenses | 4.67 | 11.26 | 3.55 | 3.21 | 3.48 | 5.70 | 3.88 | 5.49 |
| EBITDA | (2.73) | (10.06) | (1.82) | (1.36) | (1.41) | (1.57) | (0.52) | (2.73) |
| EBITDA margin | -140.7% | -838.3% | -105.2% | -73.5% | -68.1% | -38.0% | -15.5% | -98.9% |
| Depreciation | 0.60 | 0.61 | 0.71 | 0.72 | 0.68 | 0.60 | 0.77 | 0.77 |
| Interest | 0.12 | 0.14 | 0.15 | 0.17 | 0.14 | 0.06 | 0.12 | 3.04 |
| Profit before tax | 0.91 | (6.99) | 2.86 | 1.20 | 4.49 | 4.22 | 2.37 | (2.76) |
| Tax | (0.13) | (0.64) | 0.15 | 0.16 | 0.90 | 0.86 | 0.56 | (0.19) |
Financial Statements
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 226 | 188 | 181 | 178 | 186 | 194 | 198 | 202 |
| Revenue growth (YoY) | +21.2% | -3.3% | -8.5% | -11.7% | -4.0% | - | - | - |
| Other income | 1.75 | 14.46 | 5.14 | 4.32 | 6.08 | 21.16 | 3.44 | 3.91 |
| EBITDA | 35.28 | 14.93 | 11.21 | 3.42 | 11.07 | 7.68 | 0.75 | (2.28) |
| EBITDA margin | +15.6% | +8.0% | +6.2% | +1.9% | +5.9% | +4.0% | +0.4% | -1.1% |
| Depreciation | 4.11 | 4.78 | 5.01 | 12.23 | 11.56 | 4.66 | 11.74 | 11.04 |
| Interest | 18.08 | 17.69 | 17.04 | 19.06 | 18.55 | 18.68 | 19.48 | 23.68 |
| Profit before tax | 14.84 | 6.92 | (5.70) | (23.55) | (12.96) | 5.50 | (27.03) | (33.09) |
| Tax | (0.13) | (0.93) | 0.19 | (0.23) | (3.20) | (6.56) | (10.79) | (3.16) |
| Net profit | 14.97 | 7.85 | (5.89) | (23.32) | (9.76) | 12.06 | (16.24) | (29.93) |
| EPS (₹) | 5.39 | 5.68 | 0.41 | (5.25) | (1.61) | 7.47 | (3.05) | (6.81) |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 734 | 788 | 747 | 982 | 845 | 623 | 1,827 |
| Revenue growth | -6.9% | +5.5% | -23.9% | +16.2% | +35.7% | -65.9% | - |
| Other income | 30.00 | 32.25 | 22.52 | 320 | 47.10 | 49.78 | 255 |
| Total expenses | 693 | 763 | 715 | 1,008 | 788 | 576 | 1,783 |
| Employee cost | 0.00 | 81.07 | 71.87 | 71.26 | 59.27 | 55.30 | 371 |
| EBITDA | 40.63 | 24.79 | 32.51 | (26.13) | 56.86 | 46.36 | 43.99 |
| EBITDA margin | +5.5% | +3.2% | +4.4% | -2.7% | +6.7% | +7.4% | +2.4% |
| Depreciation | 19.75 | 45.88 | 44.95 | 37.81 | 39.25 | 45.51 | 239 |
| Interest | 72.34 | 82.50 | 81.79 | 60.00 | 68.93 | 75.59 | 174 |
| Profit before tax | (21.46) | (71.34) | (71.71) | 196 | (4.22) | (24.96) | (114) |
| Tax | (4.17) | (15.18) | (13.17) | 146 | 0.14 | (13.79) | (14.62) |
| Net profit | 5.52 | (25.26) | (32.14) | (66.54) | (42.65) | (42.56) | (299) |
| Net profit margin | +0.8% | -3.2% | -4.3% | -6.8% | -5.1% | -6.8% | -16.4% |
| EPS (₹) | 0.73 | (12.23) | (14.12) | 6.39 | (5.35) | (8.95) | (43.97) |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 23.55 | 23.55 | 23.55 | 23.55 | 23.55 | 23.55 | 23.55 |
| Reserves & surplus | 173 | 191 | 474 | 507 | 51.60 | 62.76 | 84.74 |
| Shareholders' funds (net worth) | 197 | 214 | 498 | 531 | 75.15 | 86.31 | 108 |
| Minority interest | (123) | (125) | 148 | 173 | 86.17 | 77.89 | 67.88 |
| Secured loans | 595 | 569 | 666 | 518 | 445 | 438 | 471 |
| Unsecured loans | 25.64 | 120 | 90.42 | 120 | 245 | 239 | 236 |
| Total debt | 620 | 689 | 756 | 639 | 690 | 677 | 707 |
| Total liabilities | 708 | 796 | 1,406 | 1,346 | 877 | 898 | 948 |
| Assets | |||||||
| Gross block | 913 | 926 | 2,073 | 2,087 | 1,003 | 1,065 | 1,746 |
| Net block | 432 | 456 | 1,038 | 1,045 | 465 | 494 | 534 |
| Capital work in progress | 9.60 | 3.83 | 1.28 | 0.73 | 0.70 | 0.50 | 0.32 |
| Investments | 14.20 | 10.70 | 7.66 | 2.46 | 0.01 | 0.01 | 0.22 |
| Inventories | 115 | 117 | 106 | 84.09 | 136 | 101 | 76.97 |
| Sundry debtors | 108 | 119 | 150 | 188 | 220 | 154 | 108 |
| Cash & bank balances | 5.51 | 15.01 | 36.42 | 30.83 | 40.07 | 56.64 | 64.13 |
| Loans & advances | 125 | 91.98 | 119 | 40.57 | 24.12 | 25.53 | 116 |
| Total current assets | 353 | 343 | 411 | 343 | 421 | 337 | 365 |
| Total current liabilities | 132 | 121 | 139 | 216 | 250 | 166 | 163 |
| Net working capital | 222 | 222 | 272 | 128 | 171 | 171 | 202 |
| Total assets | 708 | 796 | 1,406 | 1,346 | 877 | 898 | 948 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 14.14 | 17.00 | 24.47 | 14.16 | 32.03 | 41.27 | 75.88 |
| Net cash from operating activities | 128 | 86.41 | 62.46 | (6.98) | 41.27 | 71.79 | 256 |
| Net cash from investing activities | (5.02) | 81.41 | (106) | 36.20 | (4.26) | 1.65 | 1,309 |
| Net cash from financing activities | (132) | (171) | 35.89 | (18.90) | (54.88) | (82.68) | (1,600) |
| Net change in cash | (9.53) | (2.86) | (7.47) | 10.31 | (17.87) | (9.24) | (34.61) |
| Closing cash | 5.51 | 15.01 | 36.42 | 30.83 | 40.07 | 56.64 | 64.13 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | -6.9% | +5.5% | -23.9% | +16.2% | +35.7% | -65.9% | - |
| EBITDA growth | +63.9% | -23.8% | +224.4% | -146.0% | +22.7% | +5.4% | - |
| PBT growth | +69.9% | +0.5% | - | +9998.0% | +83.1% | +78.0% | +73.7% |
| Net income growth | +121.9% | +21.4% | +51.7% | -56.0% | -0.2% | +85.8% | - |
| Revenue CAGR (3Y) | -9.3% | -2.3% | +6.3% | -18.7% | -34.4% | -39.3% | -11.5% |
| EBITDA CAGR (3Y) | - | -24.2% | -11.2% | - | -30.4% | -33.5% | -38.4% |
| Profitability & leverage | |||||||
| Net income margin | -2.4% | -7.1% | -7.8% | +5.1% | -0.5% | -1.8% | -5.4% |
| Return on capital employed | - | - | 0.0% | +2.8% | 0.0% | 0.0% | 0.0% |
| Return on net worth | - | - | 0.0% | -8.3% | 0.0% | 0.0% | 0.0% |
| Debt / equity | - | - | 1.98 | 4.72 | 8.47 | 7.11 | 77.39 |
| Long-term debt / equity | - | - | 1.51 | 3.74 | 6.61 | 5.59 | 33.91 |
| Interest cover | 346.46 | -391.18 | -657.48 | -93.84 | 391.43 | 8,892.94 | -89.40 |
| Efficiency & per share | |||||||
| Fixed asset turnover | - | - | 0.39 | 0.71 | 0.82 | 0.44 | 0.58 |
| Inventory turnover | - | - | 7.85 | 8.90 | 7.12 | 7.00 | 8.19 |
| Debtors turnover | - | - | 4.43 | 4.81 | 4.51 | 4.75 | 8.76 |
| EPS (₹) | 0.73 | (12.23) | (14.12) | 6.39 | (5.35) | (8.95) | (43.97) |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 0.00 | 199.21 | 211.44 | 87.65 | 31.91 | 36.66 | 45.99 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.94 | 1.20 | 1.73 | 1.85 | 2.07 | 4.13 | 3.36 | 2.76 |
| Revenue growth (YoY) | -6.3% | -70.9% | -48.5% | -33.0% | -57.5% | - | - | - |
| Other income | 4.36 | 3.82 | 5.54 | 3.45 | 6.72 | 6.45 | 3.78 | 3.78 |
| Total expenses | 4.67 | 11.26 | 3.55 | 3.21 | 3.48 | 5.70 | 3.88 | 5.49 |
| EBITDA | (2.73) | (10.06) | (1.82) | (1.36) | (1.41) | (1.57) | (0.52) | (2.73) |
| EBITDA margin | -140.7% | -838.3% | -105.2% | -73.5% | -68.1% | -38.0% | -15.5% | -98.9% |
| Depreciation | 0.60 | 0.61 | 0.71 | 0.72 | 0.68 | 0.60 | 0.77 | 0.77 |
| Interest | 0.12 | 0.14 | 0.15 | 0.17 | 0.14 | 0.06 | 0.12 | 3.04 |
| Profit before tax | 0.91 | (6.99) | 2.86 | 1.20 | 4.49 | 4.22 | 2.37 | (2.76) |
| Tax | (0.13) | (0.64) | 0.15 | 0.16 | 0.90 | 0.86 | 0.56 | (0.19) |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 6.85 | 15.12 | 17.60 | 13.98 | 430 | 304 | 212 |
| Revenue growth | -54.7% | -14.1% | +25.9% | -96.8% | +41.3% | +43.6% | - |
| Other income | 19.53 | 17.85 | 23.64 | 596 | 48.02 | 71.17 | 278 |
| Total expenses | 21.50 | 20.79 | 30.91 | 102 | 399 | 284 | 459 |
| Employee cost | 0.00 | 5.42 | 5.97 | 5.75 | 33.67 | 32.08 | 27.30 |
| EBITDA | (14.65) | (5.67) | (13.31) | (87.82) | 31.28 | 20.55 | (247) |
| EBITDA margin | -213.9% | -37.5% | -75.6% | -628.2% | +7.3% | +6.8% | -116.7% |
| Depreciation | 2.72 | 2.87 | 2.15 | 4.52 | 34.64 | 34.63 | 88.06 |
| Interest | 0.60 | 3.85 | 2.49 | 0.45 | 68.19 | 74.72 | 69.08 |
| Profit before tax | 1.56 | 5.46 | 5.69 | 503 | (23.53) | (17.63) | (127) |
| Tax | 0.57 | 1.46 | 0.36 | 112 | (5.76) | (19.39) | (24.23) |
| Net profit | 2.58 | 2.14 | (10.80) | (8.82) | (51.33) | (52.79) | (126) |
| Net profit margin | +37.7% | +14.2% | -61.4% | -63.1% | -11.9% | -17.4% | -59.7% |
| EPS (₹) | 0.42 | 1.70 | 2.27 | 165.97 | (7.55) | 0.76 | (43.46) |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 23.55 | 23.55 | 23.55 | 23.55 | 23.55 | 23.55 | 23.55 |
| Reserves & surplus | 397 | 396 | 392 | 387 | 19.86 | 37.17 | 35.63 |
| Shareholders' funds (net worth) | 421 | 420 | 416 | 410 | 43.41 | 60.72 | 59.18 |
| Secured loans | 0.86 | 0.00 | 0.00 | 0.00 | 445 | 438 | 471 |
| Unsecured loans | 11.01 | 11.04 | 10.29 | 7.52 | 245 | 240 | 238 |
| Total debt | 11.87 | 11.04 | 10.29 | 7.52 | 690 | 678 | 709 |
| Total liabilities | 433 | 434 | 426 | 418 | 757 | 793 | 831 |
| Assets | |||||||
| Gross block | 71.44 | 76.41 | 77.95 | 54.97 | 909 | 901 | 1,586 |
| Net block | 57.62 | 60.82 | 63.41 | 16.25 | 446 | 473 | 506 |
| Capital work in progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.08 | 0.00 |
| Investments | 310 | 294 | 294 | 294 | 80.51 | 89.49 | 173 |
| Inventories | 0.18 | 0.38 | 0.51 | 0.82 | 56.23 | 44.42 | 22.22 |
| Sundry debtors | 2.04 | 3.41 | 4.89 | 9.45 | 92.63 | 72.28 | 39.10 |
| Cash & bank balances | 1.30 | 3.49 | 2.05 | 11.98 | 4.52 | 7.81 | 5.44 |
| Loans & advances | 64.86 | 76.01 | 82.67 | 0.50 | 15.88 | 18.48 | 23.59 |
| Total current assets | 68.38 | 83.29 | 90.12 | 22.75 | 169 | 143 | 90.35 |
| Total current liabilities | 18.93 | 16.18 | 33.16 | 35.31 | 170 | 135 | 142 |
| Net working capital | 49.45 | 67.11 | 56.96 | (12.56) | (0.70) | 7.66 | (51.61) |
| Total assets | 433 | 434 | 426 | 418 | 757 | 793 | 831 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 2.64 | 1.19 | 11.13 | 3.66 | 7.25 | 4.92 | 6.00 |
| Net cash from operating activities | 11.57 | 2.36 | 97.63 | 397 | 46.29 | (0.41) | 71.12 |
| Net cash from investing activities | (14.05) | 2.94 | (107) | 181 | 5.59 | 85.02 | 10.82 |
| Net cash from financing activities | 0.24 | (3.85) | (0.51) | (571) | (55.47) | (82.28) | (83.03) |
| Net change in cash | (2.24) | 1.45 | (9.94) | 7.47 | (3.59) | 2.33 | (1.08) |
| Closing cash | 1.30 | 3.49 | 2.05 | 11.98 | 4.52 | 7.81 | 5.44 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | -54.7% | -14.1% | +25.9% | -96.8% | +41.3% | +43.6% | - |
| EBITDA growth | -158.4% | +57.4% | +84.8% | -380.8% | +52.2% | +108.3% | - |
| PBT growth | -71.4% | -4.0% | -98.9% | +9998.0% | -33.5% | +86.1% | +59.7% |
| Net income growth | +20.6% | +119.8% | -22.5% | +82.8% | +2.8% | +58.2% | - |
| Revenue CAGR (3Y) | -21.2% | -67.2% | -61.3% | -59.6% | +21.5% | +5.7% | -9.5% |
| EBITDA CAGR (3Y) | -45.0% | - | - | -29.2% | - | - | +342.6% |
| Profitability & leverage | |||||||
| Net income margin | +14.5% | +26.5% | +30.3% | +2795.4% | -4.1% | +0.6% | -48.3% |
| Return on capital employed | - | +1.0% | -1.3% | -1.1% | 0.0% | +0.2% | 0.0% |
| Return on net worth | - | +0.3% | -1.7% | -2.5% | 0.0% | -14.8% | 0.0% |
| Debt / equity | - | 0.03 | 0.02 | 1.54 | 13.14 | 11.57 | 7.14 |
| Long-term debt / equity | - | 0.02 | 0.02 | 1.20 | 10.24 | 9.08 | 5.77 |
| Interest cover | -3.45 | -45.08 | -16.11 | -0.49 | -2,029.46 | -530.68 | -20.61 |
| Efficiency & per share | |||||||
| Fixed asset turnover | - | 0.20 | 0.26 | 0.03 | 0.47 | 0.24 | 0.13 |
| Inventory turnover | - | 33.98 | 26.47 | 0.49 | 8.54 | 9.13 | 7.86 |
| Debtors turnover | - | 3.64 | 2.45 | 0.27 | 5.21 | 5.46 | 5.56 |
| EPS (₹) | 0.42 | 1.70 | 2.27 | 165.97 | (7.55) | 0.76 | (43.46) |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 0.00 | 178.24 | 176.54 | 174.30 | 18.44 | 25.79 | 25.13 |
Board of Directors and KMP of Bilcare Limited
Bilcare Limited currently reports 5 directors and 3 key managerial personnel. 32 former directors have served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shreyans Mohan Bhandari Also directs: Juniper Health LLP, Jan Business Ventures Private Limited | Managing Director | 01 Jul 2022 | 4 Years 3 Months | Current |
| Mohan Harakchand Bhandari Also directs: B A Technologies Limited | Ceo | 01 Jul 1987 | 39 Years 3 Months | Current |
| Rajesh Shankarrao Devene | Director | 22 Apr 2019 | 7 Years 6 Months | Current |
| Alka Sagar | Director | 14 Aug 2024 | 2 Years 2 Months | Current |
| Sagar Ramnarayan Baheti | Company Secretary | 08 Feb 2024 | 2 Years 8 Months | Current |
| Kavita Bhansali Also directs: Bilcare Pharma Solutions Limited | Whole-Time Director | 14 Aug 2023 | 3 Years 2 Months | Current |
Peer Comparison of Bilcare Limited
Bilcare Limited is compared with the companies closest to it by revenue in the Packaging industry (Films and Foils, Pharma Packaging). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Acg Pharmapack Private Limited | ₹1,273.79 Cr (FY 2025) | •••• | •••• | -3.0% | •••• | Mumbai, Maharashtra, India |
| Datwyler Pharma Packaging India Private Limited | ₹884.78 Cr (FY 2025) | •••• | •••• | 14.0% | •••• | Satara, Maharashtra, India |
| Ultimate Flexipack Limited | ₹870.83 Cr (FY 2025) | •••• | •••• | 9.0% | •••• | New Delhi, Delhi, India |
| Shriji Polymers (India) Limited | ₹842.29 Cr (FY 2025) | •••• | •••• | 8.0% | •••• | Ujjain, Madhya Pradesh, India |
| West Pharmaceutical Packaging India Private Limited | ₹814.55 Cr (FY 2025) | •••• | •••• | -7.0% | •••• | Hyderabad, Telangana, India |
| Caprihans India Limited Listed | ₹767.56 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Khed, Maharashtra, India |
| Bilcare Limited this company | ₹733.54 Cr (FY 2026) | •••• | •••• | -6.9% | •••• | Pune, Maharashtra, India |
| Schott Glass India Private Limited | ₹696.25 Cr (FY 2025) | •••• | •••• | 15.0% | •••• | Mumbai, Maharashtra, India |
| Nahar Poly Films Limited Listed | ₹683.88 Cr (FY 2025) | •••• | •••• | 12.0% | •••• | Punjab, India |
| Kris Flexipacks Private Limited | ₹621.52 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Mumbai, Maharashtra, India |
| Svam Toyal Packaging Industries Private Limited | ₹613.93 Cr (FY 2025) | •••• | •••• | -2.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Bilcare by revenue in the Packaging industry (Films and Foils, Pharma Packaging), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Bilcare Limited
Bilcare Limited is audited by K R MINIYAR & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| K R MINIYAR & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Shareholding Pattern of Bilcare Limited
Shareholding for the quarter ended Sep 2026: promoters hold 30.00%, foreign institutional investors hold 0.00%, domestic institutional investors hold 0.00% and retail and other public shareholders hold 70.00%.
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | |
|---|---|---|---|---|
| Promoters | 30.00% | 30.00% | 30.00% | 30.00% |
| Public | 70.00% | 70.00% | 70.00% | 70.00% |
Charges & Borrowings of Bilcare Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Dec 2023 | Others | ₹50 Cr | Open |
| 28 Mar 2023 | Others | ₹616.96 Cr | Open |
| 26 Feb 2018 | Lakshmi Vilas Bank Limited | ₹91.62 Cr | Satisfied |
| 10 Jun 2015 | Others | ₹44.92 Cr | Satisfied |
| 14 Oct 2014 | Lakshmi Vilas Bank Limited | ₹25.25 Cr | Satisfied |
Total charge records: 31 View all charges
Deals & Funding of Bilcare Limited
Bilcare Limited has 37 deals on record (30 market trades, 7 funding rounds), with disclosed funding of ₹475.94 Cr; the latest was in September 2026.
Deals on record (5 of 37)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jan 2023 | Market trade | ₹4.07 Cr | Buyer: BP Equities Private Limited , 2 individuals Seller: BP Equities Private Limited , an individual |
| Nov 2022 | Market trade | ₹1.56 Cr | Buyer: Multiplier Share and Stock Advisors Private Limited , Epitome Trading And Investments Seller: Epitome Trading And Investments, Multiplier Share and Stock Advisors Private Limited , an individual |
| Feb 2021 | Market trade | ₹1.46 Cr | Buyer: Alpha Leon Enterprises LLP Seller: Alpha Leon Enterprises LLP |
| Mar 2015 | Market trade | ₹1.21 Cr | Buyer: an individual Seller: M.S. Overseas Private Limited |
| Mar 2014 | Market trade | ₹2.32 Cr | Buyer: Fidelity Multitrade Private Limited Seller: Pasha Finance Private Limited |
Full deal history
All 37 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Bilcare Limited
Bilcare Limited has 136 court cases on record: 52 filed by Bilcare, 75 filed against it, 9 where it is another party. 33 cases are pending and 103 are disposed. Status as checked between 21 Sep 2026 and 05 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 66 | 40 | 18 |
| High courts | 58 | 31 | 11 |
| NCLAT | 9 | 4 | 4 |
| Supreme Court | 3 | 0 | 0 |
Cases on record (5 of 136)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Writ petition | Filed by the company against The Bank of Baroda Limited | Pending |
| Bombay High Court | Court case (CAA) | Filed against the company by Clinirx Research Private Limited | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Civil suit | Filed by the company against Chowhan Ventures Private Limited | Pending |
| District court, Pune, Maharashtra | Civil suit | Filed against the company by Idbi Bank Limited | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Cases) | Filed against the company by Phoenix Arc Private Limited | Disposed |
Full case history
All 136 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Bilcare Limited
Bilcare Limited has a workforce of 70 employees as of Apr 10, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Group Structure of Bilcare Limited
Bilcare has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares Held |
|---|---|---|
| Caprihans India Limited | L29150MH1946PLC004877 | - |
Showing major subsidiaries. Total: 1.
Recent Activity on Bilcare Limited
Bilcare Limited has 67 board changes on record since 1987: 37 appointments and 30 cessations. The latest: Ashwini Ashok Hasabnis was appointed as Additional Director on 25 Apr 2026.
129 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Bilcare Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Bilcare Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Bilcare Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Bilcare Limited
Bilcare has 4 GST registrations: 1 active and 3 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCB2242F1Z6 | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Bilcare Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Related news about Bilcare Limited
Frequently Asked Questions about Bilcare Limited
Bilcare is an active public limited company based in Pune, Maharashtra, India. The company works in packaging films and foils, within the packaging industry. It was incorporated on 01 July 1987 (39+ years old) and is registered under CIN L28939PN1987PLC043953. Listed on BSE: 526853 and NSE: BI.
Bilcare reported revenue of ₹733.54 Cr for FY 2025-26 (down 6.9% YoY) based on consolidated financials.
Bilcare has 8 current directors and KMP:
- Shreyans Mohan Bhandari - Managing Director
- Kavita Bhansali - Whole-Time Director
- Rajesh Shankarrao Devene - Director
- Alka Sagar - Director
- Ashwini Ashok Hasabnis - Additional Director
- Mohan Harakchand Bhandari - Ceo
- Sagar Ramnarayan Baheti - Company Secretary
- Deepa Mathur - Cfo
The GSTIN of Bilcare is 27AABCB2242F1Z6, registered in Maharashtra. The company has 4 GST registrations in all, of which 1 is active and 3 are cancelled or inactive.
The CIN (Corporate Identification Number) of Bilcare is L28939PN1987PLC043953. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Bilcare is listed on both BSE (code: 526853) and NSE (symbol: BI).
Bilcare has 136 court cases on record: 52 filed by the company and 75 filed against it. 33 are pending. Most are in the district courts.
Bilcare was incorporated on 01 July 1987, making it 39+ years old. It is registered with the Registrar of Companies, Pune.
Bilcare has 37 deals on record (30 market trades, 7 funding rounds), with disclosed funding of ₹475.94 Cr; the latest was in September 2026.
The peers of Bilcare by revenue are Acg Pharmapack Private Limited, Datwyler Pharma Packaging India Private Limited, Ultimate Flexipack Limited, Shriji Polymers (India) Limited, West Pharmaceutical Packaging India Private Limited and 5 more, all in the Packaging industry (Films and Foils, Pharma Packaging).
Ashwini Ashok Hasabnis was appointed as Additional Director on 25 Apr 2026. Abhigyan Upadhyay ceased to be Director on 09 Jan 2025. Alka Sagar was appointed as Director on 14 Aug 2024. Bilcare has 67 board changes on record in total.